V-Bio Ventures

We are a life sciences fund investing throughout Europe in start-up and early-stage companies with high growth potential. Our articles cover investment-related topics in life sciences, including innovation trends, the latest business themes and exciting updates on our portfolio companies.

Confo Therapeutics: Drugging the Undruggable

Llama single-domain antibodies have found yet another application, one that Confo Therapeutics is fully exploiting. Ablynx is developing Nanobodies®, AgroSavfe […] December 13, 2016 · V-Bio Ventures

Biotech through the eyes of a financial analyst

Ward Capoen studied biology and subsequently obtained a PhD in biotechnology at Ghent University. He worked as a postdoctoral fellow […] December 9, 2016 · V-Bio Ventures

Inside a life sciences fund: V-Bio Ventures

V-Bio Ventures, the new Belgian fund for life sciences startups, is currently being managed by Christina Takke and Willem Broekaert. […] December 7, 2016 · V-Bio Ventures

V-Bio Ventures announces the final closing of its first fund, raises over €75 million

After an initial closing in November 2015, V-Bio Ventures now expands its already impressive investor roster and establishes itself as […] December 1, 2016 · V-Bio Ventures